February 2021: Pfizer Inc. and Imcyse, a Belgium-based clinical-stage biopharmaceutical company, announced a research collaboration and license agreement for the potential treatment of rheumatoid arthritis (RA) via Imcyse’s rheumatoid arthritis program based on its Imotope technology.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?